Assessment of CSF homovanillic acid levels distinguishes dementia with Lewy bodies from Alzheimer’s disease
✍ Scribed by Kazutomi Kanemaru; Hiroshi Yamanouchi
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 194 KB
- Volume
- 249
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Use of MMSE to differentiate Alzheimer's disease from dementia with Lewy bodies Dear Editor Like Dr Ala and his colleagues (Ala et al., 2002), we have encountered patients with pathologically confirmed dementia with Lewy bodies (DLB) who retro-spectively scored < 5 on the Ala MMSE subscore test
Dear Editor þ p < 0.01 as compared with the DLB group. # p < 0.01 as compared with the AD group.
Objectives. To compare patients ful®lling clinical criteria for Lewy body dementia with those meeting clinical criteria for Alzheimer's disease. Design. Prospective cohort study. Setting. Psychiatric services and a memory clinic. Sample. 124 patients with DSM-III-R dementia. Measures. The assess